Trademark: 88317262
Word
INMEDIX
Status
Registered
Status Code
700
Status Date
Tuesday, July 5, 2022
Serial Number
88317262
Registration Number
6782695
Registration Date
Tuesday, July 5, 2022
Mark Type
4000
Filing Date
Tuesday, February 26, 2019
Published for Opposition
Tuesday, July 21, 2020

Trademark Owner History
Inmedix, Inc. - Original Registrant

Classifications
9 Downloadable software for patient monitoring; downloadable software for therapeutic purposes, namely, patient monitoring; downloadable software for diagnosing, monitoring or treating medical conditions; downloadable patient monitoring and diagnostic software for conducting stress research; tablet computer device and software sold as a unit for capturing patient data
35 Business services, namely, business research services and data collection that utilize artificial intelligence, machine learning, and big data analytics for business purposes; data collection services in the field of healthcare and medicine; consulting services in the field of healthcare data collection and analytics; data collection for business purposes in the field of therapeutics, pharmaceuticals, and medical devices; business consulting services in the field of healthcare and medicine; business research and data analysis services; conducting market research for others relating to medical devices and pharmaceuticals; conducting market research for others relating to medical devices; providing consumer purchasing information about medical devices and diagnostics
44 Providing medical information; consulting services in the field of medical care; health assessment services; health counselling; medical clinic services; medical counseling; medical screening information services; providing health care information; providing health information; providing medical information to patients and medical professionals in the form of reports in the field of medical evaluations and diagnoses; providing medical testing for diagnostic or treatment purposes; providing personalized healthcare and medical information in the nature of the evaluation, management and prevention of medical conditions, symptoms and diseases; providing medical information about medical devices and diagnostics; medical diagnostic services, namely, diagnosis of factors impacting autoimmune diseases and cancer, diagnosis of severity and treatment responses for autoimmune diseases and cancer
10 Medical devices and instruments, namely, patient monitors and patient monitoring and diagnostic software sold as a unit; medical devices used for therapeutic purposes, namely, patient monitors and patient monitoring and diagnostic software sold as a unit; medical apparatus and instruments, namely, patient monitors and software for diagnosing, monitoring or treating medical conditions sold as a unit; medical apparatus and instruments, namely, patient monitors and patient monitoring and diagnostic software for conducting stress research sold as a unit
42 Providing online non-downloadable software for patient monitoring; providing online non-downloadable software for therapeutic purposes, namely, patient monitoring; providing online non-downloadable software for diagnosing, monitoring or treating medical conditions; providing online non-downloadable patient monitoring and diagnostic software for conducting stress research; scientific research and analysis services in the field of therapeutics, pharmaceuticals, and medical devices; conducting new product research for others relating to therapeutics, pharmaceuticals, and medical devices; consulting services in the field pharmaceutical research; medical research services, namely, conducting clinical trials for others; medical research services in the field of the autonomic nervous system; pharmaceutical research services; providing medical and scientific research information in the fields of pharmaceuticals and therapeutics; compiling data for research purposes in the field of medical science and medical consultancy; conducting scientific research for others relating to medical devices; consulting services in the fields of pharmaceutical research and development, medical device research and development and analytical testing; providing scientific information about medical devices and diagnostics; online non-downloadable medical device software for organizing patient records, and care coordination for use with medical data; computer technology consulting services in the field of data collection and analytics; data collection for medical research and diagnostic purposes in the field of therapeutics, pharmaceuticals, and medical devices; providing medical testing for medical research purposes and commercialization; providing medical device software, namely, software as a service (SAAS) services for analyzing human electrical signals for diagnostic purposes

Trademark Events
Jul 5, 2022
Notice Of Registration Confirmation Emailed
Jul 5, 2022
Registered-Principal Register
May 31, 2022
Notice Of Acceptance Of Statement Of Use E-Mailed
May 30, 2022
Allowed Principal Register - Sou Accepted
May 7, 2022
Statement Of Use Processing Complete
Mar 15, 2022
Use Amendment Filed
May 6, 2022
Case Assigned To Intent To Use Paralegal
Apr 8, 2022
Case Assigned To Intent To Use Paralegal
Mar 15, 2022
Teas Statement Of Use Received
Sep 17, 2021
Notice Of Approval Of Extension Request E-Mailed
Sep 15, 2021
Sou Extension 2 Granted
Sep 15, 2021
Sou Extension 2 Filed
Sep 15, 2021
Teas Extension Received
Mar 16, 2021
Notice Of Approval Of Extension Request E-Mailed
Mar 12, 2021
Sou Extension 1 Granted
Mar 12, 2021
Sou Extension 1 Filed
Mar 12, 2021
Teas Extension Received
Sep 15, 2020
Noa E-Mailed - Sou Required From Applicant
Jul 21, 2020
Official Gazette Publication Confirmation E-Mailed
Jul 21, 2020
Published For Opposition
Jul 1, 2020
Notification Of Notice Of Publication E-Mailed
Jun 16, 2020
Approved For Pub - Principal Register
Jun 5, 2020
Teas/Email Correspondence Entered
Jun 5, 2020
Correspondence Received In Law Office
Jun 5, 2020
Assigned To Lie
May 28, 2020
Teas Response To Office Action Received
Apr 28, 2020
Notification Of Examiner's Amendment/Priority Action E-Mailed
Apr 28, 2020
Examiner's Amendment/Priority Action E-Mailed
Apr 28, 2020
Combined Examiner's Amendment/Priority Action Automatic Entry
Apr 28, 2020
Examiners Amendment And/Or Priority Action - Completed
Nov 27, 2019
Notification Of Final Refusal Emailed
Nov 27, 2019
Final Refusal E-Mailed
Nov 27, 2019
Final Refusal Written
Nov 8, 2019
Teas/Email Correspondence Entered
Nov 8, 2019
Correspondence Received In Law Office
Nov 8, 2019
Teas Response To Office Action Received
May 11, 2019
Notification Of Non-Final Action E-Mailed
May 11, 2019
Non-Final Action E-Mailed
May 11, 2019
Non-Final Action Written
May 7, 2019
Assigned To Examiner
Mar 18, 2019
New Application Office Supplied Data Entered In Tram
Mar 1, 2019
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24